What is the next management step for a sedated 4-year-old male with spina bifida, chronic pulmonary hypertension, tracheostomy on mechanical ventilation, prematurity (31 weeks gestation), hypothyroidism, gastrostomy tube, ostomy, and severe respiratory syncytial virus infection who remains hypoxemic on FiO2 90% (SpO2 90%) with a respiratory rate of 60/min despite continuous albuterol nebulizations, intravenous steroids, and a ketamine infusion?

Immediate Management: Escalate Ventilatory Support and Consider Pulmonary Vasodilator Therapy

This child with severe RSV bronchiolitis, underlying pulmonary hypertension, and refractory hypoxemia on FiO2 90% requires immediate optimization of mechanical ventilation with lung recruitment strategies, initiation of inhaled nitric oxide (iNO) therapy, and preparation for potential ECMO referral if deterioration continues.

Calculate Oxygenation Index and Assess Disease Severity

First, calculate the oxygenation index (OI) to quantify severity: OI = (mean airway pressure × FiO2 × 100) / PaO2 1. While you report SpO2 of 90%, obtain an arterial blood gas to determine actual PaO2 1. An OI >25 indicates severe hypoxemic respiratory failure warranting pulmonary vasodilator therapy, and OI >40 signals need for ECMO center referral 1.

Optimize Mechanical Ventilation Strategy

Lung Recruitment Maneuvers

• Implement aggressive lung recruitment strategies immediately 1. In this child with mixed obstructive (RSV bronchiolitis) and restrictive disease (pulmonary hypertension, prematurity-related lung disease), lung recruitment can dramatically improve iNO efficacy 1.
• Target tidal volumes ≤10 mL/kg ideal body weight to minimize volutrauma 1
• Maintain plateau pressures ≤28-32 cmH2O given likely increased chest wall elastance from spina bifida 1
• Optimize PEEP (5-8 cmH2O baseline, titrate higher based on disease severity and oxygenation response) 1
• In obstructive disease with air-trapping, PEEP can facilitate triggering and reduce work of breathing 1

Consider High-Frequency Oscillatory Ventilation

If conventional ventilation optimization fails to improve oxygenation, high-frequency oscillatory ventilation (HFOV) should be considered as rescue therapy 1. However, avoid high-frequency jet ventilation in this obstructive airway disease 1.

Initiate Pulmonary Vasodilator Therapy

Inhaled Nitric Oxide (Primary Recommendation)

Start iNO immediately if OI exceeds 25 1. This child's chronic pulmonary hypertension combined with acute RSV-induced hypoxemia creates a pulmonary hypertensive crisis requiring urgent intervention.

• Initial dose: 20 ppm (doses >20 ppm increase methemoglobinemia risk without improving outcomes) 1
• Monitor for acute improvement in oxygenation within minutes to hours 1
• Critical caveat: 30-40% of patients do not respond to iNO 1. If no improvement after 4-6 hours at 20 ppm, consider adjunctive therapies rather than increasing dose 1
• When weaning (after stabilization), taper slowly to 1 ppm before discontinuation to prevent rebound pulmonary hypertension 1

Adjunctive Pulmonary Vasodilators if iNO Fails

If OI remains >25 despite iNO and optimized ventilation 1:

• Sildenafil is reasonable as adjunctive therapy (Class IIa recommendation) 1
• Inhaled prostacyclin analogs may be considered (Class IIb recommendation) 1

Assess for Left Ventricular Dysfunction

Obtain echocardiography urgently to:

• Confirm pulmonary hypertension with right-to-left shunting (essential criterion for iNO initiation) 1
• Evaluate for LV dysfunction, which may limit response to pulmonary vasodilators 1
• If LV dysfunction present, intravenous milrinone is reasonable (Class IIa) 1

Address Sedation Strategy

Ketamine Considerations

While ketamine provides sedation and bronchodilation, be aware of potential hemodynamic effects 2:

• Ketamine can cause transient increases in blood pressure and heart rate, but also decreases and arrhythmias 2
• Monitor vital signs and cardiac function continuously 2
• The current ketamine infusion may be contributing to cardiovascular instability in the setting of pulmonary hypertension 2
• Consider adding or transitioning to benzodiazepine-based sedation to reduce emergence reactions and potentially improve patient-ventilator synchrony 2

Bronchodilator Therapy Reassessment

Albuterol Efficacy

Discontinue or significantly reduce continuous albuterol if no documented clinical benefit 3, 4.

• In premature infants with bronchiolitis, albuterol use does not correlate with documented efficacy 4
• Continuous beta-agonist therapy increases cardiovascular stress (tachycardia, potential arrhythmias) 3, which is particularly dangerous in pulmonary hypertension 5
• Consider trial of racemic epinephrine instead, as premature infants show better response rates 4

Prepare for ECMO Referral

Contact an ECMO center immediately if 1:

• OI >40 (strong indication for ECMO consideration) 1
• Progressive deterioration despite iNO and optimized ventilation 1
• Hemodynamic instability develops 1

This child has multiple high-risk features for mortality: pulmonary hypertension in severe BPD carries 45% mortality 5, and tracheostomy-dependent grade 3 BPD has 11.2% predischarge mortality or need for lung transplantation 6.

Steroid Therapy Continuation

Continue IV corticosteroids 7. In severe pneumonia/ARDS, low-dose short-course corticosteroids probably reduce short-term mortality (RR 0.73-0.77) and may reduce secondary shock without increasing hospital-acquired infections 7. The current steroid regimen is appropriate for this RSV-induced severe respiratory failure.

Monitor for Complications

• Measure arterial blood gases, not just SpO2, for accurate assessment 1
• Monitor for air-trapping and intrinsic PEEP given obstructive component 1
• Assess for secondary bacterial infections, though routine tracheal aspirate cultures are not recommended—only during acute deterioration to guide antibiotic therapy 8
• Watch for tracheostomy-related complications given acute illness 8, 9

Key Pitfall to Avoid

The most critical error would be delaying iNO initiation or ECMO referral while continuing ineffective therapies. This child's combination of chronic pulmonary hypertension, severe RSV, and refractory hypoxemia on near-maximal FiO2 represents a pulmonary hypertensive crisis requiring immediate escalation beyond bronchodilators and steroids alone 1.